RECRUITING

Arizona Alzheimer's Disease Research Center (ADRC)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The Arizona Alzheimer's Disease Research Center (ADRC) is the National Institute on Aging's (NIA's) first statewide AD Center (ADC), the only ADC in the Southwestern United States, and a leading example of statewide collaboration in biomedical research. It capitalizes on Arizona's strengths in brain imaging, genomics, computer science and biomathematics, the basic, cognitive and behavioral neurosciences, clinical, and neuropathological studies of AD, the discovery and evaluation of investigational treatments, and the study of normal cognitive aging.

Official Title

Arizona Alzheimer's Disease Research Center (ADRC)

Quick Facts

Study Start:2021-10-01
Study Completion:2026-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05405075

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:40 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Not specified
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Cognitively normal persons, individuals with mild cognitive impairment or dementia who are at least 40 years of age.
  2. * Willing to undergo health and cognitive assessments, and collection and banking of blood with venipuncture for genetic research, biomarker research, and DNA banking.
  1. * 1. Participants whose diagnosis is unclear and confounded by multiple possible factors are excluded. Participants with diagnoses of non-AD dementias are not excluded.
  2. 2. Participants whose primary diagnosis is cognitive impairment due to a penetrating or single severe closed head injury, multiple sclerosis, brain tumor, metabolic or toxic encephalopathy, post-infectious (e.g., viral encephalitis, bacterial meningitis), paraneoplastic, primary psychiatric illness, or otherwise not deemed relevant to the intent of the Alzheimer Disease Center program are excluded.
  3. 3. Procedure specific exclusion criteria also apply but this does not impact the participants ability to be included in the study.

Contacts and Locations

Study Contact

Trisha Walsh
CONTACT
602.839.6029
ADRC@bannerhealth.com

Study Locations (Sites)

Banner Alzheimer's Institute
Phoenix, Arizona, 85006
United States
Barrow Neurological Institute
Phoenix, Arizona, 85013
United States
Mayo Clinic
Scottsdale, Arizona, 85259
United States
Banner Sun Health Research Institute
Sun City, Arizona, 85351
United States
Banner Alzheimer's Institute - Tucson
Tucson, Arizona, 85718
United States

Collaborators and Investigators

Sponsor: Banner Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-10-01
Study Completion Date2026-06-30

Study Record Updates

Study Start Date2021-10-01
Study Completion Date2026-06-30

Terms related to this study

Additional Relevant MeSH Terms

  • Alzheimer Disease